• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 再现:社区病毒监测检测。

Resurgence of SARS-CoV-2: Detection by community viral surveillance.

机构信息

School of Public Health, Imperial College London, London, UK.

MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.

出版信息

Science. 2021 May 28;372(6545):990-995. doi: 10.1126/science.abf0874. Epub 2021 Apr 23.

DOI:10.1126/science.abf0874
PMID:33893241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8158959/
Abstract

Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has mainly relied on case reporting, which is biased by health service performance, test availability, and test-seeking behaviors. We report a community-wide national representative surveillance program in England based on self-administered swab results from ~594,000 individuals tested for SARS-CoV-2, regardless of symptoms, between May and the beginning of September 2020. The epidemic declined between May and July 2020 but then increased gradually from mid-August, accelerating into early September 2020 at the start of the second wave. When compared with cases detected through routine surveillance, we report here a longer period of decline and a younger age distribution. Representative community sampling for SARS-CoV-2 can substantially improve situational awareness and feed into the public health response even at low prevalence.

摘要

对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行的监测主要依赖于病例报告,而病例报告受到卫生服务绩效、检测可用性和检测寻求行为的影响。我们报告了一项在英格兰进行的基于社区的全国代表性监测计划,该计划基于 2020 年 5 月至 9 月初约 59.4 万名接受 SARS-CoV-2 检测的个体的自我管理拭子结果,无论症状如何。2020 年 5 月至 7 月期间,疫情有所下降,但从 8 月中旬开始逐渐上升,在 9 月初第二波疫情开始时加速上升。与通过常规监测发现的病例相比,我们在这里报告了更长的下降期和更年轻的年龄分布。即使在低流行率的情况下,对 SARS-CoV-2 进行有代表性的社区抽样也可以大大提高对疫情的了解,并为公共卫生应对提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/a5603bb71b67/372_990_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/eec53fd52fc4/372_990_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/95247c45e684/372_990_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/a5603bb71b67/372_990_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/eec53fd52fc4/372_990_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/95247c45e684/372_990_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b303/8158959/a5603bb71b67/372_990_F3.jpg

相似文献

1
Resurgence of SARS-CoV-2: Detection by community viral surveillance.SARS-CoV-2 再现:社区病毒监测检测。
Science. 2021 May 28;372(6545):990-995. doi: 10.1126/science.abf0874. Epub 2021 Apr 23.
2
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.2020 年 4 月至 11 月英国 SARS-CoV-2 社区流行率:来自 ONS 冠状病毒感染调查的结果。
Lancet Public Health. 2021 Jan;6(1):e30-e38. doi: 10.1016/S2468-2667(20)30282-6. Epub 2020 Dec 11.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Timeliness and completeness of laboratory-based surveillance of COVID-19 cases in England.英格兰基于实验室的 COVID-19 病例监测的及时性和完整性。
Public Health. 2021 May;194:163-166. doi: 10.1016/j.puhe.2021.03.012. Epub 2021 Apr 1.
5
Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.比较基于 SARS-CoV-2 PCR 的唾液或鼻咽拭子标本在无症状人群中的检测。
Microbiol Spectr. 2021 Sep 3;9(1):e0006221. doi: 10.1128/Spectrum.00062-21. Epub 2021 Aug 25.
6
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.英格兰的 SARS-CoV-2 感染和疫苗有效性(REACT-1):一系列横断面随机社区调查。
Lancet Respir Med. 2022 Apr;10(4):355-366. doi: 10.1016/S2213-2600(21)00542-7. Epub 2022 Jan 24.
7
Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.长期护理机构工作人员中对 SARS-CoV-2 进行纵向监测的早期采用:患病率、病毒学和序列分析。
Microbiol Spectr. 2021 Dec 22;9(3):e0100321. doi: 10.1128/Spectrum.01003-21. Epub 2021 Nov 10.
8
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.2019 年冠状病毒病(COVID-19)疑似病例的人口统计学、临床和流行病学特征——美国,2020 年 1 月 17 日-2 月 29 日。
PLoS One. 2021 Apr 15;16(4):e0249901. doi: 10.1371/journal.pone.0249901. eCollection 2021.
9
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究:SARS-CoV-2逆转录实时聚合酶链反应(rtRT-PCR)检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
10
COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys.英格兰不同社会人口群组的 COVID-19 检测和报告行为:基于人群的检测数据和社区流行监测调查数据的研究。
Lancet Digit Health. 2024 Nov;6(11):e778-e790. doi: 10.1016/S2589-7500(24)00169-9.

引用本文的文献

1
SARS-CoV-2 dynamics in New York City during March 2020-August 2023.2020年3月至2023年8月纽约市的新型冠状病毒2型动态
Commun Med (Lond). 2025 Apr 7;5(1):102. doi: 10.1038/s43856-025-00826-6.
2
Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators.通过综合多个监测指标来估计挪威新冠肺炎的趋势。
PLoS One. 2025 Jan 30;20(1):e0317105. doi: 10.1371/journal.pone.0317105. eCollection 2025.
3
Jointly estimating epidemiological dynamics of Covid-19 from case and wastewater data in Aotearoa New Zealand.

本文引用的文献

1
Regressing SARS-CoV-2 Sewage Measurements Onto COVID-19 Burden in the Population: A Proof-of-Concept for Quantitative Environmental Surveillance.将 SARS-CoV-2 污水测量值回归到人群中的 COVID-19 负担:定量环境监测的概念验证。
Front Public Health. 2022 Jan 3;9:561710. doi: 10.3389/fpubh.2021.561710. eCollection 2021.
2
REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒社区传播的实时评估(REACT):研究方案。
Wellcome Open Res. 2021 Apr 21;5:200. doi: 10.12688/wellcomeopenres.16228.2. eCollection 2020.
3
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.
利用新西兰奥特亚罗瓦的病例和废水数据联合估计新冠疫情的流行病学动态。
Commun Med (Lond). 2024 Jul 15;4(1):143. doi: 10.1038/s43856-024-00570-3.
4
Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.呼吸道病毒监测在 COVID-19 大流行急性阶段后期的关键挑战
Emerg Infect Dis. 2024 Feb;30(2). doi: 10.3201/eid3002.230768. Epub 2024 Jan 8.
5
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.细菌蛋白酶作为新冠病毒感染潜在可利用的调节剂:来自文献的逻辑、信息学以及犬类的启示
BioTech (Basel). 2023 Oct 30;12(4):61. doi: 10.3390/biotech12040061.
6
A Digital Mask-Voiceprint System for Postpandemic Surveillance and Tracing Based on the STRONG Strategy.基于 STRONG 策略的后疫情监测和追踪数字口罩-声纹系统。
J Med Internet Res. 2023 Nov 6;25:e44795. doi: 10.2196/44795.
7
Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.利用系统的旅行者抵达筛查实时监测国际 SARS-CoV-2 流行情况:一项观察性研究。
PLoS Med. 2023 Sep 8;20(9):e1004283. doi: 10.1371/journal.pmed.1004283. eCollection 2023 Sep.
8
Impact of climate change on SARS-CoV-2 epidemic in China.气候变化对中国 SARS-CoV-2 疫情的影响。
PLoS One. 2023 Jul 27;18(7):e0285179. doi: 10.1371/journal.pone.0285179. eCollection 2023.
9
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.英格兰 23 个月内 SARS-CoV-2 感染住院和感染病死率的动态变化。
PLoS Biol. 2023 May 25;21(5):e3002118. doi: 10.1371/journal.pbio.3002118. eCollection 2023 May.
10
PepGM: a probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores. PepGM:一种概率图形模型,用于对具有相关置信分数的病毒蛋白质组样本进行分类推断。
Bioinformatics. 2023 May 4;39(5). doi: 10.1093/bioinformatics/btad289.
全人群快速抗原检测对斯洛伐克新冠病毒流行率的影响。
Science. 2021 May 7;372(6542):635-641. doi: 10.1126/science.abf9648. Epub 2021 Mar 23.
4
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.南非新冠病毒 501Y.V2 变异株可逃避南非捐赠者血浆的中和作用。
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
5
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.全面绘制影响多克隆人血浆抗体识别的 SARS-CoV-2 受体结合域突变图谱。
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6. doi: 10.1016/j.chom.2021.02.003. Epub 2021 Feb 8.
6
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.英格兰在大流行首次高峰后 SARS-CoV-2 抗体流行率。
Nat Commun. 2021 Feb 10;12(1):905. doi: 10.1038/s41467-021-21237-w.
7
Covid-19: New coronavirus variant is identified in UK.新冠疫情:英国发现新型冠状病毒变种。
BMJ. 2020 Dec 16;371:m4857. doi: 10.1136/bmj.m4857.
8
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next week.新冠疫情:英国批准辉瑞和生物科技公司的疫苗,下周开始推广接种。
BMJ. 2020 Dec 2;371:m4714. doi: 10.1136/bmj.m4714.